Hospital Pharmacy
Hospital pharmacy practice integrates clinical, operational and regulatory roles with workforce challenges. The session covers antimicrobial stewardship and CDC core elements, medication-error reduction, oncology pharmacy specialisation (BCOP board certification), pharmacy automation (Pyxis, Omnicell, RIVA, BD Cato), drug shortages and management, and pharmacist prescribing authority expansion. Discussion addresses 340B drug pricing programmes, the comparison of integrated pharmacy and PBM models, sterile compounding in hospitals, ICU and emergency pharmacy practice, transitions-of-care pharmacist roles, and the workforce-development pipeline.
- CDC antimicrobial stewardship
- Medication-error reduction
- Oncology BCOP
- Pyxis/Omnicell automation
- Drug-shortage management
- Pharmacist prescribing
- 340B programme
- Transitions of care pharmacist
Explore the full WCPD 2027 program
- 01Drug Discovery & Design
- 02Clinical Pharmacology
- 03Pharmacogenomics & Precision Medicine
- 04Drug Delivery Systems
- 05Toxicology & Safety Pharmacology
- 06Regulatory Science & Policy
- 07Pharmacovigilance
- 08Biopharmaceuticals
- 09Pharmaceutical Manufacturing
- 10mRNA & RNA Therapeutics
- 11Antibody Engineering
- 12Oligonucleotide Therapeutics
- 13AI for Drug Design
- 14Real-World Evidence
- 15Adaptive Clinical Trials
- 16Pharmaceutical Quality
- 17Generic & Biosimilars
- 18Access & Pricing
- 19Antimicrobial Drug Development
- 20Antiviral Drug Development
- 21Anticancer Therapies
- 22CNS Drugs
- 23Endocrine Drugs
- 24Pediatric Drug Development
- 25Geriatric Pharmacology
- 26Herbal & Natural Products
- 27Drug Repurposing
- 28Orphan Drugs
- 29Combination Therapies
- 30Drug-Drug Interactions
- 31Pharmacoeconomics
- 32Compounding Pharmacy
- 34Targeted Protein Degraders
- 35Pharmacovigilance Innovation